ADMISSION OF NEW ORDINARY SHARES
Via RNS and SGXNET
AVATION PLC
("Avation" or "the Company")
ADMISSION OF NEW ORDINARY SHARES
The Board of Avation PLC (LSE: AVAP), announces that, further to the Company's announcement on 24 June 2024 in relation to the allotment of 60,000 new ordinary shares in the capital of the Company (the "New Shares"), the listing of the New Shares in the standard segment of the Official List of the UK Listing Authority and the admission of the New Shares to trading on the London Stock Exchange's main market for listed securities ("Admission") became effective and that dealings commenced at 8.00 a.m. on 28 June 2024.
The New Shares rank pari passu in all respects with the existing ordinary shares of the Company with ISIN GB00B196F554.
Following Admission, there are a total of 70,878,124 ordinary shares in issue and there are 70,878,124 total voting rights for the purpose of calculating shareholders' percentage voting rights.
--ENDS-
Enquiries:
Avation PLC - Jeff Chatfield, Executive Chairman +65 6252 2077
Avation welcomes shareholder questions and comments and advises the email address for questions is: [email protected] and the Company provides an investor Q & A during the conference call associated with release of results. The head office telephone number is +65 6252 2077.
Notes to Editors:
Avation PLC is a commercial passenger aircraft leasing company, headquartered in Singapore, owning and managing a fleet of widebody, narrowbody jet and turboprop aircraft which it leases to airlines across the world. The Company's customers include 16 commercial airlines in 14 countries. Avation's fleet of aircraft is currently fully leased and utilised. The Company is listed on the London Stock Exchange with ticker AVAP.L, more information on Avation is available at www.avation.net.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.